These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 21780343)
1. Oxybutynin dependence: a case presentation. Mutlu EA Turk Psikiyatri Derg; 2011; 22(2):131-2. PubMed ID: 21780343 [No Abstract] [Full Text] [Related]
2. The physical dependence liabilities of oxybutynin and morphine in rats. Algate DR; Beard DJ Arzneimittelforschung; 1985; 35(10):1577-9. PubMed ID: 4074417 [TBL] [Abstract][Full Text] [Related]
7. Psychotic disorder induced by oxybutynin: Presentation of two cases. Gulsun M; Pinar M; Sabanci U Clin Drug Investig; 2006; 26(10):603-6. PubMed ID: 17163294 [TBL] [Abstract][Full Text] [Related]
8. [Neuropsychiatric adverse effects attributed to use of oxybutynin]. t'Veld BA; Kwee-Zuiderwijk WJ; van Puijenbroek EP; Stricker BH Ned Tijdschr Geneeskd; 1998 Mar; 142(11):590-2. PubMed ID: 9623118 [TBL] [Abstract][Full Text] [Related]
9. A case of oxybutynin dependency. Guloksuz S; Eren K; Gurol DT Gen Hosp Psychiatry; 2010; 32(4):e5-6. PubMed ID: 20633735 [No Abstract] [Full Text] [Related]
11. Oxybutynin-induced reflux esophagitis. Lee M; Sharifi R DICP; 1990 Jun; 24(6):583-5. PubMed ID: 2360335 [TBL] [Abstract][Full Text] [Related]
12. Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases. Gish P; Mosholder AD; Truffa M; Johann-Liang R J Pediatr; 2009 Sep; 155(3):432-4. PubMed ID: 19732583 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome. Schaefer W Int J Urol; 2007 Jul; 14(7):670; author reply 670-1. PubMed ID: 17645621 [No Abstract] [Full Text] [Related]
14. Transdermally-delivered oxybutynin (Oxytrol(R) for overactive bladder. Ho C Issues Emerg Health Technol; 2001 Oct; (24):1-4. PubMed ID: 11776281 [TBL] [Abstract][Full Text] [Related]
15. Transdermal oxybutynin for overactive bladder. Davila GW; Starkman JS; Dmochowski RR Urol Clin North Am; 2006 Nov; 33(4):455-63, viii. PubMed ID: 17011381 [TBL] [Abstract][Full Text] [Related]
16. Transdermal oxybutynin: sticking to the facts. Cartwright R; Cardozo L Eur Urol; 2007 Apr; 51(4):907-14; discussion 914. PubMed ID: 17157979 [TBL] [Abstract][Full Text] [Related]